Detection of occult hepatitis B and window period infection among blood donors by individual donation nucleic acid testing in a tertiary care center in South India

References

• Puri P. Tackling the Hepatitis B disease burden in India. J Clin Exp Hepatol. 2014;4(4):312–319.
   Google Scholar
• Allain JP. Occult Hepatitis B virus infection. Hep B Annual. 2005;2:14–30.
   Google Scholar
• Urbani S, Fagnoni F, Missale G, Franchini M. The role of anti-core antibody response in the detection of occult Hepatitis B virus infection. Clin Chem Lab Med. 2010;48:23–29.
   PubMed Web of Science ®Google Scholar
• Asim M, Ali R, Khan LA, Husain SA, Singla R¸ Kar P. Significance of anti- HBc screening of blood donors and its association with occult Hepatitis B virus infection: implications for blood transfusion. Indian J Med Res. 2010;132:312–317.
   PubMed Web of Science ®Google Scholar
• Ismail AM, Devakumar S, Anantharam R, Fletcher GJ, Subramani T, John GT, et al. Low frequency of occult hepatitis B infection in anti-HBc seropositive blood donors: experience from a tertiary care centre in South India. Blood Transfus. 2012;10(2):230–232.
   PubMed Web of Science ®Google Scholar
• Doda V, Arora S, Kirtania T. Serological characterization of occult hepatitis B virus infection among blood donors in India. Transfus Apher Sci. 2014;51(2):162–167.10.1016/j.transci.2014.07.008
   PubMed Web of Science ®Google Scholar
• Allain JP. Occult hepatitis B virus infection. Transfus Clin Biol. 2004;11:18–25.10.1016/j.tracli.2003.11.007
   PubMed Web of Science ®Google Scholar
• Kleinman SH, Busch MP. Assessing the impact of HBV NAT on window period reduction and residual risk. J Clin Virol. 2006;36(Suppl 1):S23–S29.10.1016/S1386-6532(06)80005-3
   Google Scholar
• Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M, et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol. 2008;49:652–657.10.1016/j.jhep.2008.07.014
   PubMed Web of Science ®Google Scholar
• Raimondo G, Pollicino T, Romanò L, Zanetti AR. A 2010 update on occult hepatitis B infection. Pathol Biol. 2010;58:254–257, Paris.10.1016/j.patbio.2010.02.003
   PubMed Web of Science ®Google Scholar
• Hollinger FB. Hepatitis B virus infection and transfusion medicine: science and the occult. Transfusion. 2008;48:1001–1012.10.1111/j.1537-2995.2008.01701.x
   PubMed Web of Science ®Google Scholar
• Chemin I, Trépo C. Clinical impact of occult HBV infections. J Clin Virol. 2005;34(Suppl 1):S15–S21.10.1016/S1386-6532(05)80005-8
   Google Scholar
• Candotti D, Allain JP. Transfusion-transmitted hepatitis B virus infection. J Hepatol. 2009;51:798–809.10.1016/j.jhep.2009.05.020
   PubMed Web of Science ®Google Scholar
• Hoofnagle JH, Seefe LB, Bales ZB, Zimmerman HJ. Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N Engl J Med. 1978;298:1379–1383.10.1056/NEJM197806222982502
   PubMed Web of Science ®Google Scholar
• Mosley JW, Stevens CE, Aach RD, Hollinger FB, Mimms LT, Solomon LR, et al. Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients. Transfusion. 1995;35(1):5–12.10.1046/j.1537-2995.1995.35195090661.x
   PubMed Web of Science ®Google Scholar
• Allain JP. On behalf of the ISBT TTI working party “HBV safety” study-group. Characterization of “occult” HBV yield cases identified by NAT (ID or small pool) or anti-HBc screening. Available from: http://www.isbtweb.org/files/documentation/ISBT-HBV-5
   Google Scholar
• Chaudhuri V, Nanu A, Panda SK, Chand P. Evaluation of serologic screening of blood donors in India reveals a lack of correlation between anti-HBc titer and PCR amplified HBV DNA. Transfusion. 2003;43:1442–1448.10.1046/j.1537-2995.2003.00512.x
   PubMed Web of Science ®Google Scholar
• Panigrahi R, Biswas A, Datta S, Banerjee A, Chandra PK¸ Mahapatra PK, et al. Anti-hepatitis B core antigen testing with detection and characterization of occult hepatitis B virus by an in-house nucleic acid testing among blood donors in Behrampur, Ganjam, Orissa in southeastern India: implications for transfusion. Virol J. 2010;7:204–210.10.1186/1743-422X-7-204
   PubMed Web of Science ®Google Scholar
• Bhattacharya P, Chandra PK, Datta S, Banerjee A¸ Chakraborty S, Rajendran K, et al. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection. World J Gastroenterol. 2007;13:3730–3733.10.3748/wjg.v13.i27.3730
   PubMed Web of Science ®Google Scholar
• Hollinger FB. Hepatitis B virus infection and transfusion medicine: science and the occult. Transfusion. 2008;48:1001–1026.10.1111/j.1537-2995.2008.01701.x
   PubMed Web of Science ®Google Scholar
• Yang MH, Li L, Hung YS, Hung CH, Allain JP, Lin KS, et al. The efficacy of individual-donation and minipool testing to detect low-level hepatitis B virus DNA in Taiwan. Transfusion. 2010;50:65–74.10.1111/trf.2010.50.issue-1
   PubMed Web of Science ®Google Scholar
• Yuen MF, Wong DKH, Lee CK, Tanaka Y, Allain JP, Fung J, et al. Transmissibility of hepatitis B virus (HBV) infection through blood transfusion from blood donors with occult HBV infection. Clin Infect Dis. 2011;52:624–632.10.1093/cid/ciq247
   PubMed Web of Science ®Google Scholar
• Hollinger FB, Sood G. Occult hepatitis B virus infection: a covert operation. J Viral Hepat. 2010;17:1–15.10.1111/jvh.2009.17.issue-1
   PubMed Web of Science ®Google Scholar
• Bell TG, Makondo E, Martinson NA, Kramvis A. Hepatitis B virus infection in human immunodeficiency virus infected Southern African adults: occult or overt - that is the question. Plos One. 2012;7(10):e45750.10.1371/journal.pone.0045750
   Google Scholar
• Makroo RN, Chowdhry M, Bhatia A, Arora B, Rosamma NL. Hepatitis B core antibody testing in Indian blood donors: a double-edged sword! Asian J Transfus Sci. 2012;6(1):10–13.10.4103/0973-6247.95043
   PubMedGoogle Scholar